Have a feature idea you'd love to see implemented?
Let us know!
ELMD Electromed Inc
Price (delayed)
$27.73
Market cap
$234.54M
P/E Ratio
36.97
Dividend/share
N/A
EPS
$0.75
Enterprise value
$220.68M
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague,
Highlights
The net income has surged by 100% year-on-year and by 26% since the previous quarter
Electromed's EPS has soared by 92% YoY and by 25% from the previous quarter
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter
ELMD's P/E is 36% above its last 4 quarters average of 27.1 and 14% above its 5-year quarterly average of 32.5
The company's quick ratio fell by 8% YoY and by 4.9% QoQ
Key stats
What are the main financial stats of ELMD
Market
Valuations
Earnings
Shares outstanding
8.46M
Market cap
$234.54M
Enterprise value
$220.68M
Price to earnings (P/E)
36.97
Price to book (P/B)
5.77
Price to sales (P/S)
4.16
EV/EBIT
24.66
EV/EBITDA
22.66
EV/Sales
3.87
Revenue
$57.06M
Gross profit
$43.72M
Net income
$6.47M
EBIT
$8.95M
EBITDA
$9.74M
Free cash flow
$11.41M
Per share
Balance sheet
Liquidity
EPS
$0.75
EPS diluted
$0.72
Free cash flow per share
$1.33
Book value per share
$4.8
Revenue per share
$6.66
TBVPS
$5.63
Total assets
$48.92M
Total liabilities
$7.43M
Debt
$0
Equity
$41.49M
Working capital
$33.59M
Debt to equity
0
Current ratio
5.53
Quick ratio
4.88
Net debt/EBITDA
-1.42
Margins
Efficiency
Dividend
EBITDA margin
17.1%
Gross margin
76.6%
Net margin
11.3%
Operating margin
14.7%
Return on assets
13.1%
Return on equity
15.3%
Return on invested capital
31.3%
Return on capital employed
21.6%
Return on sales
15.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELMD stock price
How has the Electromed stock price performed over time
Intraday
0.91%
1 week
-1.6%
1 month
-5.07%
1 year
157.95%
YTD
154.17%
QTD
29.16%
Financial performance
How have Electromed's revenue and profit performed over time
Revenue
$57.06M
Gross profit
$43.72M
Operating income
$8.38M
Net income
$6.47M
Gross margin
76.6%
Net margin
11.3%
ELMD's operating income has surged by 104% year-on-year and by 27% since the previous quarter
The net income has surged by 100% year-on-year and by 26% since the previous quarter
Electromed's operating margin has surged by 77% YoY and by 23% QoQ
Electromed's net margin has soared by 74% YoY and by 20% from the previous quarter
Growth
What is Electromed's growth rate over time
Valuation
What is Electromed stock price valuation
P/E
36.97
P/B
5.77
P/S
4.16
EV/EBIT
24.66
EV/EBITDA
22.66
EV/Sales
3.87
Electromed's EPS has soared by 92% YoY and by 25% from the previous quarter
ELMD's P/E is 36% above its last 4 quarters average of 27.1 and 14% above its 5-year quarterly average of 32.5
The price to book (P/B) is 99% higher than the 5-year quarterly average of 2.9 and 80% higher than the last 4 quarters average of 3.2
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter
The stock's price to sales (P/S) is 66% more than its 5-year quarterly average of 2.5 and 66% more than its last 4 quarters average of 2.5
ELMD's revenue is up by 15% year-on-year and by 4.3% since the previous quarter
Efficiency
How efficient is Electromed business performance
The ROIC has soared by 116% YoY and by 32% from the previous quarter
Electromed's ROS has soared by 83% YoY and by 22% from the previous quarter
The company's return on assets has surged by 77% YoY and by 22% QoQ
The ROE has soared by 74% YoY and by 23% from the previous quarter
Dividends
What is ELMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELMD.
Financial health
How did Electromed financials performed over time
Electromed's total liabilities has increased by 27% YoY but it has decreased by 3.4% QoQ
The current ratio has declined by 12% year-on-year and by 3.8% since the previous quarter
Electromed's debt is 100% less than its equity
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.